人冠状动脉粥样硬化病灶内CD40L水平与病灶结构变化的关系
作者:
作者单位:

(贵州医科大学 1.病理学教研室, ;2.法医学教研室, ;3.法医司法鉴定中心, 贵州省贵阳市 550004)

作者简介:

耿俊梅,硕士研究生,研究方向为分子病理学,E-mail为505604870@qq.com。

基金项目:

贵州省高校工程技术研究中心建设项目(黔科合KY字[2013]114)


Relationship between CD40L level and lesion structure in human coronary atherosclerotic lesions
Author:
Affiliation:

1.Department of Pathology, ;2.Department of Forensic Medicine, ;3.Medicolegal Expertise Center, Guizhou Medical University, Guiyang, Guizhou 550004, China)

  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
    摘要:

    目的 观察人冠状动脉粥样硬化病灶结构变化、CD40L、基质金属蛋白酶9(MMP-9)蛋白表达水平,探讨CD40/CD40L信号在人冠状动脉粥样硬化发生发展中的作用。 方法 收集不同程度粥样硬化的人冠状动脉血管60例作为实验组,以12例无病变的人冠状动脉为对照组,常规HE染色观察两组人群冠状动脉的组织结构并用图像分析软件检测病灶结构的相关指标,免疫组织化学染色检测CD40L、MMP-9蛋白表达水平,分析CD40L、MMP-9表达水平与动脉硬化病灶结构变化之间的关系。 结果 发生粥样硬化的冠状动脉CD40L表达均增强,其表达主要分布于斑块肩部和底部的泡沫细胞。同时病灶内MMP-9表达水平增高并与CD40L水平、病灶大小尤其是坏死灶的大小呈正相关,MMP-9表达水平与纤维帽厚度无明显相关性。随着MMP-9水平增高,纤维帽厚度/内膜最大厚度比值降低。 结论 人冠状动脉粥样硬化病灶内CD40L、MMP-9表达水平明显增强,CD40L可能通过促进MMP-9表达,使血管病灶内细胞外基质分解加强,从而促进病变的进展及坏死灶的扩大,使粥样病灶稳定性下降。

    Abstract:

    Aim To observe the structural changes of human coronary atherosclerotic lesions and the expression of CD40L and matrix metalloproteinase-9 (MMP-9) protein, and to explore the role of CD40/CD40L signaling in the development of human coronary atherosclerosis. Methods 60 cases of human coronary artery with different degrees of atherosclerosis were collected as experimental group, and 12 cases without pathological changes were as control group. HE staining was used to observe the histological structure of coronary artery in the two groups, and image analysis software was used to detect the related indexes of the lesion structure. The expression levels of CD40L and MMP-9 protein were detected by immunohistochemical staining. The relationship between the expression of CD40L and MMP-9 and the structural changes of atherosclerotic lesions were analyzed. Results The expression of CD40L protein was enhanced in all the atherosclerotic coronary artery, and it was mainly expressed in the foam cells of the plaques shoulder and bottom. Moreover, the expression level of MMP-9 protein in the lesion was increased and it was positively correlated with the CD40L expression and the lesion size especially the necrosis size. There was no correlation between the expression level of MMP-9 and the thickness of fibrous cap. The ratio of fibrous cap thickness to the maximum intimal thickness was decreased with the increase of MMP-9 level. Conclusions The expressions of CD40L and MMP-9 protein are significantly enhanced in the human coronary atherosclerotic lesions. CD40L may promote the expression of MMP-9, to strengthen the extracellular matrix decomposition in vascular lesions, so as to promote the development of lesions and the enlargement of necrotic foci, thus the stability of atherosclerotic lesions is decreased.

    参考文献
    [1] Souza CF, Doi H, Mintz GS, et al.Morphological changes and clinical impact of unstable plaques within untreated segments of acute myocardial infarction patients during a 3-year follow-up:an analysis from the HORIZONS-AMI trial.Coron Artery Dis, 5,6 (6):469-475.
    [2] Mach F, Schonbeck U, Sukhova GK, et al.Functional CD40 ligand is expression on human vascular endothelial cells, smooth muscle cells, and macrophages:Implication for CD40/CD40L ligand signaling in atherosclerosis.Practice Natl Acad Sci USA, 7,4(5):1 931-936.
    [3] Mach F, Schonbeck U, Sukhova GK, et al.Reduction of atherosclerosis in mice by inhibition of CD40 signalling.Nature, 8,4(6689):200-203.
    [4] Eivazi S, Bagheri S, Hashemzadeh MS, et al.Development of T follicular helper cells and their role in disease and immune system.Biomed Pharmacother, 6,4:1 668-678.
    [5] Chen C, Chai H, Wang X, et al.Soluble CD40 ligand induces endothelial dysfunction in human and porcine coronary artery endothelial cells.Blood, 8,2(8):3 205-216.
    [6] Hassan GS, Merhi Y, Mourad W.CD40 ligand:a neo-inflammatory molecule in vascular diseases.Immunobiology, 2,7(5):521-532.
    [7] Hansson GK, Libby P, Tabas I.Inflammation and plaque vulnerability.J Intern Med, 5,8(5):483-493.
    [8] Zhang B, Wu T, Chen M, et al.The CD40/CD40L system:a new therapeutic target for disease.Immunol Lett, 3,3(1-2):58-61.
    [9] Ahmadsei M, Lievens D, Weber C, et al.Immune-mediated and lipid-mediated platelet function in atherosclerosis.Curr Opin Lipidol, 5,6(5):438-448.
    [10] Gremmel T, Frelinger AL 3rd, Michelson AD.Soluble CD40 ligand in aspirin-treated patients undergoing cardiac catheterization.PLoS One, 5,0(8):e0 134 599.
    [11] 严金川, 吴宗贵, 仲人前, 等.CD40/CD40L共同表达于人内皮细胞及人动脉粥样斑块中.中国病理生理杂志, 2,9(8):1 021-024.
    [12] Setianto BY, Hartopo AB, Achadiono DN, et al.Association between levels of circulating soluble CD40 ligand on admission and in-hospital events among acute coronary syndrome patients.Acta Med Indones, 1,3(2):82-87.
    [13] Grufman H, Schiopu A, Edsfeldt A, et al.Evidence for altered inflammatory and repair responses in symptomatic carotid plaques from elderly patients.Atherosclerosis, 4,7(1):177-182.
    [14] 张峻, 陈纪林, 顾晴, 等.抗血小板药物与阻断CD40信号对动脉粥样硬化的影响.中国循环杂志, 8,3(1):57-61.
    [15] Oeckinghaus A, Hayden MS, Ghosh S.Crosstalk in NF-kappa B signaling pathways.Nat Immunol, 1,2(8):695-708.
    [16] 李建军, 马清峰, 张静, 等.高血压患者颈动脉粥样硬化与其血清CD40/CD40L及MMP-9水平的关系.微循环学杂志, 4,4(1):32-34.
    [17] Mittal R, Patel AP, Debs LH, et al.Intricate functions of matrix metalloproteinases in physiological and pathological conditions.J Cell Physiol, 6,1(12):2 599-621.
    [18] Arpino V, Brock M, Gill SE.The role of TIMPs in regulation of extracellular matrix proteolysis.Matrix Biol, 2015, S44-S46:247-254.
    [19] 康彬, 陈树涛, 冯津萍.探讨MMP-9、TIMP-1、MMP-9/TIMP-1及ICTP与冠心病的相关性.中国医学创新, 5,2(12):18-21.
    [20] 马清峰, 李建军, 熊亮, 等.血清CD40、CD40L和基质金属蛋白酶-9水平与颈动脉内膜中层厚度的相关性.中国老年学杂志, 6,6(8):1 947-949.
    引证文献
引用本文

耿俊梅,万昌武,乐翠云,刘江金,王玉,黄江.人冠状动脉粥样硬化病灶内CD40L水平与病灶结构变化的关系[J].中国动脉硬化杂志,2017,25(4):355~359.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2017-01-03
  • 最后修改日期:2017-01-16
  • 在线发布日期: 2017-05-18